BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32565024)

  • 41. Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice.
    Bi X; Pohl NM; Qian Z; Yang GR; Gou Y; Guzman G; Kajdacsy-Balla A; Iozzo RV; Yang W
    Carcinogenesis; 2012 Feb; 33(2):326-30. PubMed ID: 22159220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.
    Makino S; Takahashi H; Okuzaki D; Miyoshi N; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Mizushima T; Mori M; Doki Y
    Carcinogenesis; 2020 May; 41(3):303-312. PubMed ID: 31562741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-431 inhibits colorectal cancer cell invasion via repressing CUL4B.
    Su WB; Liu ZY
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3047-3052. PubMed ID: 29863249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
    Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
    Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-κB signaling.
    Yan Z; Yin H; Wang R; Wu D; Sun W; Liu B; Su Q
    Acta Histochem; 2014 Apr; 116(3):527-33. PubMed ID: 24360977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
    Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.
    Huang HC; Hu CH; Tang MC; Wang WS; Chen PM; Su Y
    Oncogene; 2007 Apr; 26(19):2781-90. PubMed ID: 17072345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells.
    Satow R; Hirano T; Batori R; Nakamura T; Murayama Y; Fukami K
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13505-10. PubMed ID: 25197077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TNNT1, a prognostic indicator in colon adenocarcinoma, regulates cell behaviors and mediates EMT process.
    Hao YH; Yu SY; Tu RS; Cai YQ
    Biosci Biotechnol Biochem; 2020 Jan; 84(1):111-117. PubMed ID: 31512553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
    Zhang Z; Bu X; Chen H; Wang Q; Sha W
    Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
    Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
    J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
    Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
    Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of SPARC in the epithelial-mesenchymal transition induced by PTHrP in human colon cancer cells.
    Carriere P; Calvo N; Novoa Díaz MB; Lopez-Moncada F; Herrera A; Torres MJ; Alonso E; Gandini NA; Gigola G; Contreras HR; Gentili C
    Mol Cell Endocrinol; 2021 Jun; 530():111253. PubMed ID: 33781836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.